Valion Bio, Inc.
VBIO
$2.44
-$0.06-2.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.53% | -117.69% | -9.75% | -34.44% | -28.56% |
| Total Depreciation and Amortization | 236.46% | 5,933.33% | -- | -100.00% | 0.00% |
| Total Amortization of Deferred Charges | 9.89% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.11% | 3.44% | -34.72% | 190.95% | 17.75% |
| Change in Net Operating Assets | 127.59% | 107.14% | 300.00% | 121.88% | -121.67% |
| Cash from Operations | -5.39% | -119.11% | -14.58% | -9.25% | -105.51% |
| Capital Expenditure | -714.29% | 72.00% | -150.00% | -233.33% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | 96.77% |
| Cash from Investing | -714.29% | 95.30% | -1,390.00% | 50.00% | 96.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -77.52% | 1,650.46% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 216.31% | 541.54% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -79.55% | 81.67% | -366.67% | 168.70% | -385.19% |
| Cash from Financing | 625.00% | -100.38% | 172.26% | 80.86% | 2,780.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.89% | -155.05% | 305.78% | 340.00% | 138.63% |